Walid Abi-Saab

Chief Tech/Sci/R&D Officer chez UNIQURE N.V.

Fortune : 606 840 $ au 31/03/2024

59 ans

Health Technology

Consumer Services

Postes actifs de Walid Abi-Saab

Sociétés	Poste	Début	Fin
UNIQURE N.V.	Chief Tech/Sci/R&D Officer	26/06/2023	-

Sociétés	Poste	Début	Fin
GALAPAGOS NV	Chief Tech/Sci/R&D Officer	01/03/2017	31/12/2022
Shire International GmbH (Switzerland) Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals.	Corporate Officer/Principal	-	-
SHIRE	Corporate Officer/Principal	-	-
Yale School of Medicine	Corporate Officer/Principal	-	-

American University of Beirut	Undergraduate Degree
Université Saint-Joseph	Doctorate Degree

Internationale

Opérationnelle

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	2
Undergraduate Degree	1

Sectorielle

Health Technology	5
Consumer Services	4

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
GALAPAGOS NV	Health Technology
UNIQURE N.V.	Health Technology

Entreprise privées	2
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland.	Health Technology
Shire International GmbH (Switzerland) Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals.	Health Technology

Entreprise privées

Health Technology